AADAC antibody (C-Term)
Quick Overview for AADAC antibody (C-Term) (ABIN452700)
Target
See all AADAC AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects Arylacetamide deacetylase at C-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human AADAC
-
-
-
-
Application Notes
-
ELISA: 1: 1,000. Western blot: 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.52 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
-
-
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Alternative Name
- AADAC
-
Background
- Microsomal arylacetamide deacetylase (AADAC) competes against the activity of cytosolic arylamine N-acetyltransferase which catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. Arylacetamide deacetylation by AADAC is also important in the metabolic activation of some arylamine substrates to carcinogens.Synonyms: CES5A1, DAC, arylacetamide deacetylase
-
Gene ID
- 13
-
NCBI Accession
- NP_001077
-
UniProt
- P22760
Target
-